Urinary proteomic profiles distinguish between active and inactive lupus nephritis.
about
Human Urine Proteomics: Analytical Techniques and Clinical Applications in Renal DiseasesBiomarkers of systemic lupus erythematosus identified using mass spectrometry-based proteomics: a systematic reviewA proteomic study of peripheral blood mononuclear cells in systemic lupus erythematosus.Temporal stability of the urinary proteome after kidney transplant: more sensitive than protein composition?Identification of candidate molecular markers predicting chemotherapy resistance in non-small cell lung cancer.Urinary proteomics as a novel tool for biomarker discovery in kidney diseases.Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarraysSELDI-TOF-MS proteomic profiling of serum, urine, and amniotic fluid in neural tube defects.Urinary biomarkers in lupus nephritis.Mass spectrometry-based proteomics in Chest Medicine, Gerontology, and Nephrology: subgroups omics for personalized medicine.urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitisUrine proteomics: the present and future of measuring urinary protein components in diseaseContributions of mass spectrometry-based proteomics to defining cellular mechanisms and diagnostic markers for systemic lupus erythematosus.Urinary angiostatin--a novel putative marker of renal pathology chronicity in lupus nephritis.Biomarkers of lupus nephritis determined by serial urine proteomicsBiomarkers in systemic lupus erythematosus: challenges and prospects for the future.Beyond immunosuppression - challenges in the clinical management of lupus nephritis.Urine proteomes of healthy aging humans reveal extracellular matrix (ECM) alterations and immune system dysfunction.The novel diagnostic biomarkers for focal segmental glomerulosclerosis.Urinary proteomics--a tool for biomarker discovery.Biomarkers for lupus nephritis: a critical appraisal.Proteome analysis of biological fluids from autoimmune-rheumatological disorders.Lupus arthritis--do we have a clinically useful classification?Diagnosis and treatment of lupus nephritis flares--an update.The applied basic research of systemic lupus erythematosus based on the biological omics.Ten developments in the use of biologicals for systemic lupus erythematosus.Biomarkers in lupus nephritis.Unveiling the rat urinary proteome with three complementary proteomics approaches.Identification of potential biomarkers for systemic lupus erythematosus diagnosis using two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry.Annexin A2 and FTH1 are potential biomarkers for lupus nephritis
P2860
Q26773607-733DADB3-121E-456A-AB7D-F70AD20C49E3Q28071491-FF2480B4-DBC2-4752-998E-16FFAE8E68C3Q33364673-469922D9-3145-4AB4-AF4C-9BF401DD5AC4Q33384709-EBE2B4A0-98CA-4E6A-B980-7738B6AAA811Q33546556-16F4E8E4-A31D-4DAB-B793-00F8A7916A61Q33781011-D5F650D0-2D11-4D62-B0F6-B8C30D0ABF7CQ33829507-34FE82E8-A1F7-48AA-B55B-94BBC79EB7CCQ33940289-EE746D10-240B-481D-86D9-2209DCCE076FQ34050022-5D9B8AD8-9B5C-4EDE-97E9-4218BEDC4E12Q34691573-1EF216E5-DD4D-416F-8BFD-1C588AFB3B75Q35861689-685134B3-1364-4663-985A-4F6624671236Q35929449-60F6D629-0CE7-49B3-8EBB-50291FE11737Q36084958-460206C4-74CA-4513-B869-761A8E82B697Q36832462-D035A040-A8F1-44D9-ADDE-22458D22ABAFQ37038307-FB6ED82D-5DEE-440D-BED1-7435A944645BQ37058781-6C69A9DE-25C8-435A-908F-67DE82F6ED7AQ37371383-E7EDEB11-AAF6-4F06-A4D2-95EBE3265EC5Q37471129-82ED92F8-7853-4753-AABC-D57AA2177189Q37699843-CFDFC67D-6FBB-44CA-A1AE-18B20CBAC483Q37701845-0A1E1DD0-DE41-481D-9009-F7C96F368BD6Q37736277-A65D888B-A475-47E1-95C5-876860BA406DQ37830007-5F3232E0-4D3C-4AE6-AE04-DE5AD3439BB8Q37969656-39CD76F9-7859-491A-AFA3-1A406D6D6FD7Q38059445-C12BF039-5DDD-4EA2-82FE-B956E3338A46Q38085206-32A430FC-0F6B-408E-8E6E-072B2D283951Q38105959-F344A9C3-9433-4035-8C0A-96EBF42004EBQ38425837-C4684072-66FB-4992-92A1-6A127DA1F2AAQ43939756-2D820F5E-18F5-434D-B17E-87D7B8D5A770Q50908478-E59714B6-724B-4828-9917-4A4427849A0AQ57787123-AF1860D4-9738-4CB2-9A12-F3D26C5EFD32
P2860
Urinary proteomic profiles distinguish between active and inactive lupus nephritis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Urinary proteomic profiles distinguish between active and inactive lupus nephritis.
@ast
Urinary proteomic profiles distinguish between active and inactive lupus nephritis.
@en
type
label
Urinary proteomic profiles distinguish between active and inactive lupus nephritis.
@ast
Urinary proteomic profiles distinguish between active and inactive lupus nephritis.
@en
prefLabel
Urinary proteomic profiles distinguish between active and inactive lupus nephritis.
@ast
Urinary proteomic profiles distinguish between active and inactive lupus nephritis.
@en
P2093
P356
P1433
P1476
Urinary proteomic profiles distinguish between active and inactive lupus nephritis
@en
P2093
P304
P356
10.1093/RHEUMATOLOGY/KEL351
P50
P577
2006-10-17T00:00:00Z